Showing results (591-600 of 980) with videos related to

Sort By:
Pageof 98
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2021
An introgressed gene causes meiotic drive in Neurospora sitophilaJesper Svedberg, Aaron A Vogan, Nicholas A Rhoades, et al.
JACS Au|November 30, 2023
Antibody-Based Imaging of Bioreductive Prodrug Release in HypoxiaÇağla Tosun, Antoine L D Wallabregue, Maxim Mallerman, et al.
Sports Medicine (Auckland, N.Z.)|February 18, 2018
Fuel for the Work Required: A Theoretical Framework for Carbohydrate Periodization and the Glycogen Threshold HypothesisSamuel G Impey, Mark A Hearris, Kelly M Hammond, et al.
Angewandte Chemie (International Ed. in English)|July 7, 2026
Harnessing the Reactivity of Sulfinate Salts With Cystine: An Umpolung Approach to Residue-Specific Peptide ModificationJoshua M Hammond, Esteban Suárez-Picado, Lena von Sydow, et al.
The Journal of Head Trauma Rehabilitation|November 6, 2019
Ethical Considerations in Chronic Brain InjuryLenore Hawley, Flora M Hammond, Alison M Cogan, et al.
Bioinformatics (Oxford, England)|December 19, 2008
Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistanceFuxiao Xin, Meng Li, Curt Balch, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2012
Radiosensitization of renal cell carcinoma in vitro through the induction of autophagySelvakumar Anbalagan, Isabel M Pires, Christopher Blick, et al.
Cell Death Discovery|July 2, 2026
Tirapazamine sensitises hypoxic homologous recombination-proficient NSCLC to PARP inhibitionYanyan Jiang, Nuria Vilaplana Lopera, Hala Estephan, et al.
The Journal of Head Trauma Rehabilitation|August 18, 2006
The accuracy of artificial neural networks in predicting long-term outcome after traumatic brain injuryMary E Segal, Philip H Goodman, Richard Goldstein, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1992
In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandinK Bartizal, G Abruzzo, C Trainor, et al.
Pageof 98